pronativ human prothrombin complex powder for injection vial and solution for injection vial
octapharma australia pty ltd - factor x, quantity: 360 iu; plasma proteins, quantity: 260 mg; protein c, quantity: 140 iu; protein s, quantity: 140 iu; factor ii, quantity: 220 iu; factor vii, quantity: 180 iu; factor ix, quantity: 500 iu - injection, solution - excipient ingredients: water for injections - treatment of bleeding and perioperative prophylaxis of bleeding in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required. as a second line therapy for the control of bleeding episodes and surgical prophylaxis in patients with congenital factor vii deficiency, for whom recombinant human fviia has failed, is contraindicated or has been associated with unacceptable adverse effects.
veraseal solutions for sealant 2 ml (human fibrinogen 80 mg/ml syringe 1 ml / human thrombin 500 iu/ml syringe 1 ml)
grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.
veraseal solutions for sealant 10 ml (human fibrinogen 80 mg/ml syringe 5 ml / human thrombin 500 iu/ml syringe 5 ml)
grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.
veraseal solutions for sealant 4 ml (human fibrinogen 80 mg/ml syringe 2 ml / human thrombin 500 iu/ml syringe 2 ml)
grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.
veraseal solutions for sealant 6 ml (human fibrinogen 80 mg/ml syringe 3 ml / human thrombin 500 iu/ml syringe 3 ml)
grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.
uman albumin solution for infusion 200 gl
duo medical pte. ltd. - human albumin (human plasma protein containing at least 95% albumin) - infusion, solution - 200 g/l - human albumin (human plasma protein containing at least 95% albumin) 200 g/l
gammagard s/d 0.5 g/30 m micromol pdr+solv for soln for inf
baxter healthcare limited - human plasma protein >90% gamma globulin - pdr+solv for soln for inf - 0.5 g/30 m micromol
hepatect cp 50 iu/ml; solution for infusion
biotest pharma gmbh - human plasma protein; hbs antibodies - solution for infusion - 50 international unit(s)/millilitre - specific immunoglobulins; hepatitis b immunoglobulin
octaplasma solution
octapharma pharmazeutika produktionsges m b h - human plasma proteins - solution - 14g - human plasma proteins 14g - hemostatics
tisseel ready to use solutions for sealant
baxter healthcare limited - human fibrinogen; aprotinin; human factor xiii; human thrombin; calcium chloride - solution for sealant - . - local hemostatics; tissue adhesives